I-Mab Biopharma
IMAB
#9150
Rank
โ‚ฌ72.03 M
Marketcap
0,88ย โ‚ฌ
Share price
-3.17%
Change (1 day)
-37.13%
Change (1 year)

Revenue for I-Mab Biopharma (IMAB)

Revenue in 2024 (TTM): โ‚ฌ3.25 Million

According to I-Mab Biopharma's latest financial reports the company's current revenue (TTM ) is โ‚ฌ3.43 Million. In 2022 the company made a revenue of -โ‚ฌ30.77 Million a decrease over the revenue in the year 2021 that were of โ‚ฌ13.22 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for I-Mab Biopharma from 2017 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ3.25 M
2022-โ‚ฌ30.77 Million-332.55%
2021โ‚ฌ13.22 M-94.16%
2020 โ‚ฌ0.22 B5407.66%
2019 โ‚ฌ4.11 M-45.08%
2018 โ‚ฌ7.48 M340.25%
2017โ‚ฌ1.7 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.21 M-93.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.68 B 19,728.62%๐Ÿ‡บ๐Ÿ‡ธ USA